Novavax
NVAX
#2027
Rank
$6.57 B
Marketcap
$86.91
Share price
12.56%
Change (1 day)
-41.27%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: $6.57 Billion

As of January 2022 Novavax has a market cap of $6.57 Billion. This makes Novavax the world's 2027th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Novavax from 2001 to 2022

Year Market cap Change
2022$6.40 B-52.24%
2021$13.40 B88.79%
2020$7.09 B5413.03%
2019$0.12 B-81.8%
2018$0.70 B51.97%
2017$0.46 B36.2%
2016$0.34 B-84.91%
2015$2.26 B59.93%
2014$1.41 B32.57%
2013$1.06 B282.07%
2012$0.27 B93.02%
2011$0.14 B-46.31%
2010$0.26 B1.17%
2009$0.26 B104.01%
2008$0.13 B-36.63%
2007$0.20 B-18.57%
2006$0.25 B20.22%
2005$0.21 B63.42%
2004$0.12 B-38.1%
2003$0.20 B220.84%
2002$0.06 B-80.23%
2001$0.32 B

End of Day market cap according to different sources

On Jan 25th, 2022 the market cap of Novavax was reported to be:

$5.83 Billion
by Yahoo Finance
$5.83 Billion
by CompaniesMarketCap
$5.83 Billion
by Nasdaq
$6.83 Billion
by Reuters
$5.83 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$189.86 B 2,789.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$298.63 B 4,444.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$178.47 B 2,616.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$112.27 B 1,608.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.19 B-5.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.70 B-89.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.02 B-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.82 B-57.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.52 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA